Nature Communications (Sep 2019)

Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy

  • Madoka Iida,
  • Kentaro Sahashi,
  • Naohide Kondo,
  • Hideaki Nakatsuji,
  • Genki Tohnai,
  • Yutaka Tsutsumi,
  • Seiya Noda,
  • Ayuka Murakami,
  • Kazunari Onodera,
  • Yohei Okada,
  • Masahiro Nakatochi,
  • Yuka Tsukagoshi Okabe,
  • Shinobu Shimizu,
  • Masaaki Mizuno,
  • Hiroaki Adachi,
  • Hideyuki Okano,
  • Gen Sobue,
  • Masahisa Katsuno

DOI
https://doi.org/10.1038/s41467-019-12282-7
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 15

Abstract

Read online

Spinal and bulbar muscular atrophy is a neuromuscular disease caused by an expanded CAG repeat in the androgen receptor gene. Here the authors show that Src kinase signaling is activated in a mouse model of the disease, and that Src inhibition improves pathology and behavioral symptoms in mice.